HDM2 and HDMX dual inhibitor 3-nitrile quinoline derivative and preparation method and application thereof

A technology of nitrile quinoline and derivatives, which is used in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc. Cancer effects, etc.

Inactive Publication Date: 2014-05-21
JIANGSU TANGGUO MEDICINE SCI & TECH
View PDF0 Cites 25 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] As a structurally similar protein to HDM2, HDMX was discovered several years later than HDM2, but the function of this protein has not been fully appreciated until the latest research published by Cancer Cell in 2010 pointed out that HDMX can also bind to p53 protein so that it cannot exert its tumor suppressor effect. Therefore, it can be used as a target for tumor drug development. In 2012, Nature Medicine also published a research paper from an independent laboratory pointing out

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HDM2 and HDMX dual inhibitor 3-nitrile quinoline derivative and preparation method and application thereof
  • HDM2 and HDMX dual inhibitor 3-nitrile quinoline derivative and preparation method and application thereof
  • HDM2 and HDMX dual inhibitor 3-nitrile quinoline derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] Example 1: 3-isopropoxy-4-methylnitrobenzene (1)

[0068] Add 60g (0.39mol) of 3-hydroxy-4-methylnitrobenzene and 100g (0.72mol) of potassium carbonate into a 500ml three-necked flask, dissolve in 300ml of acetone, stir mechanically, and slowly add 50ml of 2-bromopropane ( 0.50mol), react at 40°C for 6 hours. Then the reaction liquid was poured into 1000 ml of water, extracted three times with chloroform, the extract was concentrated, and vacuum-dried to obtain 72.2 g of a brownish-yellow liquid product with a yield of 95%. Molecular formula: C10H13NO3, molecular weight: 195.22

[0069] MS (EI) m / z 195.

Embodiment 2

[0070] Example 2: 3-isopropoxy-4-methylaniline (2)

[0071] Add 41g (0.73mol) of iron powder, 200ml of water, 50ml of acetic acid and 50ml of ethanol into a 500ml three-necked bottle, stir and heat to 30°C for 20min, then slowly drop 3-isopropoxy-4-methyl Nitrobenzene 60g (0.31mol), reacted at 50°C for 2 hours, suction filtered, combined filtrates, extracted 3 times with chloroform, concentrated the extract, and dried in vacuo to obtain 45g of brown oily liquid. Yield 89%. Molecular formula: C10H15NO, molecular weight: 165.24.

[0072] MS (EI) m / z 165.

Embodiment 3

[0073] Example 3: (Z)-2-cyano-3-(3-isopropoxy-4-methylphenyl-amino)-acrylic acid ethyl ester (3)

[0074] Add 45g (0.27mol) of 3-isopropoxy-4-methylaniline, 51g (0.30mol) of (Z)-3-ethoxy-2-nitrile-ethyl acrylate and 160ml of toluene into a 250ml three-necked flask , heated and stirred, refluxed for 4 hours, cooled to room temperature, a large amount of white solid was precipitated, filtered with suction, recovered toluene in the filtrate, and the filter cake was recrystallized with ethanol to obtain 72 g of the product, with a yield of 93%. Molecular formula: C16H20N2O3, molecular weight: 288.35. Mp: 138°C.

[0075] MS (EI) m / z 288.

[0076] 1 H-NMR (AV-500, δ, DMSO-d 6 ):1.21-1.28(m,9H);2.08(s,3H);4.14-4.26(t,2H);4.55-4.57(m,1H);6.81-6.89(m,2H);7.01-7.02(d ,1H);8.26-8.39(t,1H);10.58-10.68(d,1H)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of pharmaceutical chemistry, and in particular relates to a HDM2 and HDMX dual inhibitor 3-nitrile quinoline derivative and a preparation method and application thereof. The invention provides the quinoline derivative whose structure is shown in formula (I) or a pharmaceutically acceptable salt thereof. The compound provided by the invention can inhibit the respective ability of combining with p53 specificity of HDM2 and HDMX, can be used as an anti-tumor drug, and has a wide clinical application prospect.

Description

technical field [0001] The invention belongs to the field of chemical pharmacy, and in particular relates to a 3-cyanoquinoline derivative of HDM2 and HDMX dual inhibitor and its preparation method and application. Background technique [0002] The p53 gene is a powerful tumor suppressor gene, located on human chromosome 17p13.1, encoding a 53kD nuclear phosphorylated protein composed of 393 amino acids, called p53 protein. The p53 gene is a negative regulator in the cell growth cycle, which is related to important biological functions such as cell cycle regulation, DNA repair, cell differentiation, and cell apoptosis. Why does the human body still have cancer when there are powerful tumor suppressor genes such as the p53 gene in the human body? This is because there are two ways that the p53 tumor suppressor gene cannot effectively exert its tumor suppressor effect. One is that p53 mutation (deletion) leads to p53 structure abnormality and thus loses its normal function. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D215/54C07D401/12C07D417/12C07D417/14A61K31/496A61K31/5377A61K31/4709A61P35/00
CPCC07D401/12C07D215/54C07D417/12C07D417/14
Inventor 王森曹鑫曹聪戴振亚陆爱军
Owner JIANGSU TANGGUO MEDICINE SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap